Home Carmot Therapeutics

Carmot Therapeutics

acquired
Series E
Developer of New Drugs for Metabolic Diseases and Cancer

Basic Information

Carmot Therapeutics, Inc. is a biotechnology company focused on discovering innovative drugs for the treatment of metabolic diseases, cancer, and inflammation. Carmot's vision is to become a leader in drug discovery by unlocking new therapeutic target spaces currently inaccessible through conventional small-molecule technologies.
Carmot Therapeutics, Inc.
Berkeley,California,United States of America
less than 15 people
January 01, 2008
info@carmot.us